<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3">
 <label>3.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stupp</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Mason</surname>
    <given-names>WP</given-names>
   </name>
   <name>
    <surname>van den Bent</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Weller</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Fisher</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Taphoorn</surname>
    <given-names>MJ</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma</article-title>. 
  <source>N Engl J Med.</source> (
  <year>2005</year>) 
  <volume>352</volume>:
  <fpage>987</fpage>â€“
  <lpage>96</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa043330</pub-id>
  <pub-id pub-id-type="pmid">15758009</pub-id>
 </mixed-citation>
</ref>
